Literature DB >> 33503349

Effect of CD47 Blockade on Vascular Inflammation.

Kai-Uwe Jarr1, Ryusuke Nakamoto1, Brandon H Doan1, Yoko Kojima1, Irving L Weissman1, Ranjana H Advani1, Andrei Iagaru1, Nicholas J Leeper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33503349      PMCID： PMC8175009          DOI： 10.1056/NEJMc2029834

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  The Role of Efferocytosis in Atherosclerosis.

Authors:  Yoko Kojima; Irving L Weissman; Nicholas J Leeper
Journal:  Circulation       Date:  2017-01-31       Impact factor: 29.690

Review 2.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

3.  Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.

Authors:  Ahmed Tawakol; Zahi A Fayad; Robin Mogg; Achilles Alon; Michael T Klimas; Hayes Dansky; Sharath S Subramanian; Amr Abdelbaky; James H F Rudd; Michael E Farkouh; Irene O Nunes; Chan R Beals; Sudha S Shankar
Journal:  J Am Coll Cardiol       Date:  2013-05-30       Impact factor: 24.094

4.  CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.

Authors:  Ranjana Advani; Ian Flinn; Leslie Popplewell; Andres Forero; Nancy L Bartlett; Nilanjan Ghosh; Justin Kline; Mark Roschewski; Ann LaCasce; Graham P Collins; Thu Tran; Judith Lynn; James Y Chen; Jens-Peter Volkmer; Balaji Agoram; Jie Huang; Ravindra Majeti; Irving L Weissman; Chris H Takimoto; Mark P Chao; Sonali M Smith
Journal:  N Engl J Med       Date:  2018-11-01       Impact factor: 91.245

5.  CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

Authors:  Yoko Kojima; Jens-Peter Volkmer; Kelly McKenna; Mete Civelek; Aldons Jake Lusis; Clint L Miller; Daniel Direnzo; Vivek Nanda; Jianqin Ye; Andrew J Connolly; Eric E Schadt; Thomas Quertermous; Paola Betancur; Lars Maegdefessel; Ljubica Perisic Matic; Ulf Hedin; Irving L Weissman; Nicholas J Leeper
Journal:  Nature       Date:  2016-07-20       Impact factor: 49.962
  5 in total
  16 in total

Review 1.  Inflammation Resolution: Implications for Atherosclerosis.

Authors:  Amanda C Doran
Journal:  Circ Res       Date:  2022-01-07       Impact factor: 17.367

Review 2.  Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.

Authors:  Jacqueline T Vuong; Ashley F Stein-Merlob; Arash Nayeri; Tamer Sallam; Tomas G Neilan; Eric H Yang
Journal:  J Am Coll Cardiol       Date:  2022-02-15       Impact factor: 24.094

Review 3.  2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.

Authors:  Kai-Uwe Jarr; Yoko Kojima; Irving L Weissman; Nicholas J Leeper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-04-07       Impact factor: 10.514

Review 4.  Transcriptional determinants of cancer immunotherapy response and resistance.

Authors:  Romi Gupta; Amitkumar Mehta; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2022-02-03

5.  CD47 antibody protects mice from doxorubicin-induced myocardial damage by suppressing cardiomyocyte apoptosis.

Authors:  Yan Hao; Lianghua Chen; Zhilong Jiang
Journal:  Exp Ther Med       Date:  2022-03-24       Impact factor: 2.751

Review 6.  Emerging Concepts of Vascular Cell Clonal Expansion in Atherosclerosis.

Authors:  Ashish Misra; Rajan Rehan; Alexander Lin; Sanjay Patel; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-02-03       Impact factor: 10.514

Review 7.  Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors:  Alan H Baik; Katy K Tsai; David Y Oh; Mandar A Aras
Journal:  Clin Sci (Lond)       Date:  2021-03-12       Impact factor: 6.124

Review 8.  Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases.

Authors:  Eunhye Ji; Sahmin Lee
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 9.  Inflammation, Infection and Venous Thromboembolism.

Authors:  Meaghan E Colling; Benjamin E Tourdot; Yogendra Kanthi
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

Review 10.  Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.

Authors:  Shannon M Kelley; Kodi S Ravichandran
Journal:  EMBO Rep       Date:  2021-05-27       Impact factor: 9.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.